Ipamorelin 5mg
$45.00
Ipamorelin 5mg is a synthetic pentapeptide studied as a selective growth hormone secretagogue for research into GH receptor signaling and endocrine pathways.
Certificate of Analysis
Important Notice
Research Use Only. Not for human or animal consumption.
These products are intended exclusively for laboratory and scientific research by qualified professionals. They are not intended for human or veterinary use and are not approved to diagnose, treat, cure, or prevent any disease.
Description
Ipamorelin is a synthetic pentapeptide that acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a), the receptor pathway also activated by ghrelin. Research has investigated its ability to stimulate growth hormone release and its selectivity within related endocrine signaling pathways.
Preclinical and early human research has examined ipamorelin in relation to growth hormone secretion and gastrointestinal physiology. However, clinical evidence remains limited, and previous development programs did not establish effectiveness for postoperative ileus. The FDA has also identified characterization, impurity, stability, and potential immunogenicity concerns regarding ipamorelin acetate, particularly in compounded injectable formulations.
The 5mg specification refers to the quantity of research material supplied in the product. Ipamorelin is not an FDA-approved therapeutic product.
